News
DVAX
--
0.00%
--
Stricter FDA standards make COVID-19 vaccine approval unlikely before election day
The Washington Post reports that tougher FDA standards for emergency use authorization ((EUA)) of a COVID-19 vaccine will extend the review timeline and make it unlikely that a nod could
Seekingalpha · 2h ago
Global vaccine plan gains momentum, U.S. not on board
An $18B initiative to ensure any future vaccine against COVID-19 is fairly shared throughout the world has secured the backing of 156 countries and territories, representing about 64% of the
Seekingalpha · 12h ago
Valneva and Dynavax Announced Commercial Supply Agreement for Inactivated, Adjuvanted COVID-19 Vaccine; Dynavax to Provide CpG 1018 to Produce up to 190M Doses over a Five-Year Period
Valneva SE ("Valneva"), a specialty vaccine company focused on prevention of diseases with major unmet needs, and Dynavax Technologies Corporation (Nasdaq: DVAX) today announced a commercial partnership for the supply of Dynavax's CpG 1018 adjuvant for use in Valneva's SARS-CoV-2 vaccine candidate, VLA2001.
Benzinga · 09/14 09:58
Valneva and Dynavax Announce Commercial Supply Agreement for Inactivated, Adjuvanted COVID-19 Vaccine
Valneva SE ("Valneva"), a specialty vaccine company focused on prevention of diseases with major unmet needs, and Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced a commercial partnership for
PR Newswire · 09/14 05:00
Is Dynavax Technologies (NASDAQ:DVAX) Using Too Much Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Simply Wall St. · 09/07 16:08
3 Heavily Shorted Coronavirus Vaccine Stocks
MotleyFool.com · 09/03 06:10
Prepare for coronavirus vaccine as soon as late October - CDC
The Centers for Disease Control and Prevention ((CDC)) has notified public health officials in all 50 states and five large cities to prepare for the distribution of a COVID-19 vaccine
Seekingalpha · 09/02 19:32
AstraZeneca starts U.S. final-stage trial of COVID-19 Vaccine
AstraZeneca (NYSE:AZN) has expanded development of its COVID-19 vaccine AZD1222 into Phase III clinical trial in the U.S. to assess its safety, efficacy an
Seeking Alpha - Article · 09/01 06:45
Dynavax to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference
EMERYVILLE, Calif., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that Ryan Spencer, Chief Executive Officer, will participate in a virtual fireside chat at the H.C
GlobeNewswire · 08/31 21:10
Sanofi plans to start human testing of COVID-19 vaccine next week - Bloomberg
"Sanofi (SNY) expects to move to a large late-stage trial with an experimental coronavirus vaccine toward the end of the year," said CEO Paul Hudson at a conference in France.If
Seekingalpha · 08/27 13:46
Dynavax's Restructuring: A Work In Progress
Dynavax has finally found a home for its discarded cancer therapies, albeit one with little near- or mid-term upside.
Seeking Alpha - Article · 08/26 08:22
Flavourless Recipe For Dynavax Technologies Is Hurting Shareholders
Seeking Alpha - Article · 08/25 16:27
Can you get coronavirus a second time? A new study says yes
Researchers at the University of Hong Kong say they have proved the "first case" of reinfection of COVID-19, marking the first such documented case in the
Seeking Alpha - Article · 08/25 07:43
Dynavax: Ready To Return To Bullish
After months of remaining neutral on the ticker, I am returning to a bullish outlook for DVAX in anticipation HEPLISAV-B's numbers improve.
Seeking Alpha - Article · 08/24 14:04
GlaxoSmithKline: Attention Is Now Shifting To Vaccine Manufacturing
Current state of COVID-19 vaccine production indicates that GSK is both in vaccine development and manufacturing.
Seeking Alpha - Article · 08/21 13:39
Dynavax nabs $3.4M grant to increase capacity of COVID-19 adjuvant
The Bill & Melinda Gates Foundation has awarded a $3.4M grant to Dynavax (DVAX) to fund the expansion of production capacity for its CpG 1018 adjuvant up to 750M doses
Seekingalpha · 08/13 12:36
Dynavax nabs $3.4M grant to increase capacity of COVID-19 adjuvant
The Bill & Melinda Gates Foundation has awarded a $3.4M grant to Dynavax (DVAX) to fund the expansion of production capacity for its CpG 1018 adjuvant up to 750M doses
Seekingalpha · 08/13 12:36
Dynavax Reports $3.4M Grant From Bill & Melinda Gates Foundation To Scale Up cpG 1018 Adjuvant Capacity To Support Coronavirus Reponse
Benzinga · 08/13 12:23
DVAX Dynavax Technologies Option Alert: Aug 21 $7 Calls at the Ask: 300 @ $0.69 vs 554 OI; Ref=$6.903
Benzinga · 08/12 16:39
Dynavax Shares Move Higher As Traders Circulate bioRxiv Abstract For 'Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19'
https://www.biorxiv.org/content/10.1101/2020.08.11.245704v1
Benzinga · 08/12 14:55